BACKGROUND: Long-lasting increases in dendritic spine density and gene expression in the nucleus accumbens and in the ambulatory response to cocaine occur following chronic cocaine treatment. Despite numerous reports of these findings, the molecular mechanisms leading to these morphological, biochemical, and behavioral changes remain unclear. METHODS: We used mice genetically lacking Kalirin7 (Kal7(KO)), a Rho guanine nucleotide exchange factor that regulates dendritic spine formation and function. Both wild-type (Wt) and Kal7(KO) mice were given high-dose cocaine (20 mg/kg) for 4 or 8 consecutive days. Locomotor sensitization and conditioned place preference elicited by cocaine were evaluated. The nucleus accumbens core was diolistically labeled and spine density and morphology were quantified using confocal microscopy. RESULTS: Cocaine increased Kalirin7 messenger RNA and protein expression in the nucleus accumbens of Wt mice. The Kal7(KO) animals showed greater locomotor sensitization to cocaine than Wt mice. In contrast, Kal7(KO) mice exhibited decreased place preference for cocaine, despite displaying a normal place preference for food. While Wt mice showed a robust increase in dendritic spine density after 4 and 8 days of cocaine treatment, dendritic spine density failed to increase in cocaine-exposed Kal7(KO) mice. Wild-type mice treated with cocaine for 8 days exhibited larger dendritic spines than cocaine-treated Kal7(KO) mice. CONCLUSIONS: Kalirin7 is an essential determinant of dendritic spine formation following cocaine treatment. The absence of this single isoform of one of the many Rho guanine nucleotide exchange factors expressed in the nucleus accumbens results in enhanced locomotor sensitization and diminished place preference in response to cocaine. Copyright 2010 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.
BACKGROUND: Long-lasting increases in dendritic spine density and gene expression in the nucleus accumbens and in the ambulatory response to cocaine occur following chronic cocaine treatment. Despite numerous reports of these findings, the molecular mechanisms leading to these morphological, biochemical, and behavioral changes remain unclear. METHODS: We used mice genetically lacking Kalirin7 (Kal7(KO)), a Rho guanine nucleotide exchange factor that regulates dendritic spine formation and function. Both wild-type (Wt) and Kal7(KO) mice were given high-dose cocaine (20 mg/kg) for 4 or 8 consecutive days. Locomotor sensitization and conditioned place preference elicited by cocaine were evaluated. The nucleus accumbens core was diolistically labeled and spine density and morphology were quantified using confocal microscopy. RESULTS: Cocaine increased Kalirin7 messenger RNA and protein expression in the nucleus accumbens of Wt mice. The Kal7(KO) animals showed greater locomotor sensitization to cocaine than Wt mice. In contrast, Kal7(KO) mice exhibited decreased place preference for cocaine, despite displaying a normal place preference for food. While Wt mice showed a robust increase in dendritic spine density after 4 and 8 days of cocaine treatment, dendritic spine density failed to increase in cocaine-exposed Kal7(KO) mice. Wild-type mice treated with cocaine for 8 days exhibited larger dendritic spines than cocaine-treated Kal7(KO) mice. CONCLUSIONS: Kalirin7 is an essential determinant of dendritic spine formation following cocaine treatment. The absence of this single isoform of one of the many Rho guanine nucleotide exchange factors expressed in the nucleus accumbens results in enhanced locomotor sensitization and diminished place preference in response to cocaine. Copyright 2010 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.
Authors: P Penzes; R C Johnson; R Sattler; X Zhang; R L Huganir; V Kambampati; R E Mains; B A Eipper Journal: Neuron Date: 2001-01 Impact factor: 17.173
Authors: Bryan Kolb; Grazyna Gorny; Yilin Li; Anne-Noël Samaha; Terry E Robinson Journal: Proc Natl Acad Sci U S A Date: 2003-08-25 Impact factor: 11.205
Authors: Kelly L Conrad; Kuei Y Tseng; Jamie L Uejima; Jeremy M Reimers; Li-Jun Heng; Yavin Shaham; Michela Marinelli; Marina E Wolf Journal: Nature Date: 2008-05-25 Impact factor: 49.962
Authors: Dani Dumitriu; Quincey Laplant; Yael S Grossman; Caroline Dias; William G Janssen; Scott J Russo; John H Morrison; Eric J Nestler Journal: J Neurosci Date: 2012-05-16 Impact factor: 6.167
Authors: Shamsideen A Ojelade; Tianye Jia; Aylin R Rodan; Tao Chenyang; Julie L Kadrmas; Anna Cattrell; Barbara Ruggeri; Pimphen Charoen; Hervé Lemaitre; Tobias Banaschewski; Christian Büchel; Arun L W Bokde; Fabiana Carvalho; Patricia J Conrod; Herta Flor; Vincent Frouin; Jürgen Gallinat; Hugh Garavan; Penny A Gowland; Andreas Heinz; Bernd Ittermann; Mark Lathrop; Steven Lubbe; Jean-Luc Martinot; Tomás Paus; Michael N Smolka; Rainer Spanagel; Paul F O'Reilly; Jaana Laitinen; Juha M Veijola; Jianfeng Feng; Sylvane Desrivières; Marjo-Riitta Jarvelin; Gunter Schumann; Adrian Rothenfluh Journal: Proc Natl Acad Sci U S A Date: 2015-07-13 Impact factor: 11.205
Authors: Jodi E Eipper-Mains; Drew D Kiraly; Dasaradhi Palakodeti; Richard E Mains; Betty A Eipper; Brenton R Graveley Journal: RNA Date: 2011-06-27 Impact factor: 4.942
Authors: J E Eipper-Mains; D D Kiraly; M O Duff; M J Horowitz; C J McManus; B A Eipper; B R Graveley; R E Mains Journal: Genes Brain Behav Date: 2012-11-27 Impact factor: 3.449
Authors: Laura N Smith; Jakub P Jedynak; Miles R Fontenot; Carly F Hale; Karen C Dietz; Makoto Taniguchi; Feba S Thomas; Benjamin C Zirlin; Shari G Birnbaum; Kimberly M Huber; Mark J Thomas; Christopher W Cowan Journal: Neuron Date: 2014-05-07 Impact factor: 17.173